Tsunayuki Kakimoto

Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity

Norihide Sato, Yutaka Hattori, Wenlin Du et al. · Japanese Journal of Cancer Research · 2002 · 48 citations · Full text

Medicine, Hematology, Pathology +12

Thalidomide for the Treatment of Refractory Multiple Myeloma: Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome

Tsunayuki Kakimoto, Yutaka Hattori, Shinichiro Okamoto et al. · Japanese Journal of Cancer Research · 2002 · 29 citations · Full text

Medicine, Hematology, Pharmacology +11

Thalidomide-Induced Severe Neutropenia during Treatment of Multiple Myeloma

Yutaka Hattori, Tsunayuki Kakimoto, Shinichiro Okamoto et al. · International Journal of Hematology · 2004 · 24 citations

Medicine, Hematology, Oncology +14

Refractory Plasmablastic Type Myeloma with Multiple Extramedullary Plasmacytomas and Massive Myelomatous Effusion: Remarkable Response with a Combination of Thalidomide and Dexamethasone

Tomonori Nakazato, Kazuhito Suzuki, Ai Mihara et al. · Internal Medicine · 2009 · 21 citations · Full text

Medicine, Hematology, Oncology +17

Single‐institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: Prognostic factors and unique toxicity profile

Yutaka Hattori, Shinichiro Okamoto, Naoki Shimada et al. · Cancer Science · 2008 · 18 citations · Full text

Medicine, Oncology, Pharmacotherapy +17